Mcgauley Thomas
Tenax Therapeutics, Inc. · Interim CFO
Mcgauley Thomas is listed in filings as Interim CFO at Tenax Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 3, 2026, including purchase activity. Recent filings connect the profile to Tenax Therapeutics, Inc. (TENX). The current snapshot covers public activity from Nov 19, 2025 to Feb 3, 2026. Reported amounts are shown as $625.5K to $14.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||